Related Experiment Video
Updated: Mar 18, 2026
09:32
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.7K
Complementary and Alternative Medicine for Atopic Dermatitis: An Evidence-Based Review
Brittany L Vieira1, Neil R Lim1, Mary E Lohman1
1Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
American Journal of Clinical Dermatology
|July 9, 2016
Summary
Complementary and alternative therapies show promise for atopic dermatitis (AD) management. Evidence supports acupuncture, massage, and certain supplements, but more research is needed for clinical recommendations.
Area of Science:
- Dermatology
- Integrative Medicine
- Evidence-Based Medicine
Background:
- Growing use of complementary and alternative medicine (CAM) for atopic dermatitis (AD).
- Limited clinical utility of existing CAM studies due to quality and size.
- Need for comprehensive review of high-quality evidence.
Purpose of the Study:
- To systematically review randomized controlled trials (RCTs) of CAM therapies for AD.
- Assess the evidence base for various complementary and alternative interventions.
Main Methods:
- Searched major databases (PubMed, Cochrane, EMBASE, GREAT) for AD RCTs.
- Included studies with ≥10 participants, published in English by March 2015.
- Analyzed 70 eligible manuscripts.
Main Results:
- Level I evidence supports acupuncture, acupressure, stress reduction (hypnosis, massage, biofeedback), balneotherapy, some herbal preparations, botanical oils, evening primrose oil, vitamin D, and topical vitamin B12.
- Many other therapies lack sufficient evidence or are shown to be ineffective.
Conclusions:
- Several promising CAM therapies for AD identified.
- Further research is necessary to strengthen clinical recommendations for CAM in AD treatment.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
01:20Asthma: Pathogenesis and Management
1.6K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.6K
01:19Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K